SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001019056-18-000952
Filing Date
2018-08-10
Accepted
2018-08-10 20:38:15
Documents
2
Period of Report
2018-08-01

Document Format Files

Seq Description Document Type Size
1 ownership.html 3  
1 ownership.xml 3 11774
2 EXHIBIT 24 ex_24.htm EX-24 6692
  Complete submission text file 0001019056-18-000952.txt   19795
Mailing Address 2401 4TH AVE. SUITE 1050 SEATTLE WA 98121
Business Address 2401 4TH AVE. SUITE 1050 SEATTLE WA 98121 206-838-0500
Aptevo Therapeutics Inc. (Issuer) CIK: 0001671584 (see all company filings)

IRS No.: 811567056 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2401 4TH AVENUE SUITE 1050 SEATTLE WA 98121
Business Address
Adelman Michael (Reporting) CIK: 0001749435 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37746 | Film No.: 181010096